Category ""
ADVERTISING
Elahere (mirvetuximab soravtansine-gynx) is an injectable antibody-drug conjugate that may be used to treat adults with folate receptor-alpha (FRα) -positive platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have already received 1 to 3 prior systemic treatments.
ELAHERE is indicated for the treatment of adult patients with folate receptor-alpha (FRα) positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received one to three prior systemic treatment regimens.
What is ELAHERE? ELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive (FRα+) ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who: have not responded to or are no longer responding to treatment with platinum-based chemotherapy and; have received 1 to 3 prior types of chemotherapy.
100mg/20mL (5mg/mL) Ovarian Cancer Indicated for adults with folate receptor–alpha (FRα) positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer,...
Elahere is a cancer medicine used for the treatment of adult patients with advanced cancers of the ovaries fallopian tubes (the tubes connecting ovaries to the uterus) and the peritoneum (the membrane lining the abdomen).
ELAHERE® is indicated for the treatment of adult patients with folate receptor-alpha (FRα) positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have ...
Elahere (mirvetuximab soravtansine-gynx) is a prescription drug used to treat ovarian cancer. Learn about its uses, cost, dosage, side effects, and more.
ELAHERE® is indicated for the treatment of adult patients with folate receptor-alpha (FRα) positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have...
Elahere (mirvetuximab soravtansine-gynx) is commonly used to treat certain ovarian, fallopian tube, and peritoneal cancers. Your Guide to Elahere for Ovarian, Fallopian Tube, or Peritoneal...
Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. [1] [4] Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate. [4] [5]